Daunorubicin, Dexamethasone, Methotrexate, Rituximab, and Vincristine
About
Membership operator: AND
Therapies: 5
Therapies
Daunorubicin (tx:ncit:C62091)
Dexamethasone (tx:ncit:C422)
Methotrexate (tx:ncit:C642)
Rituximab (tx:ncit:C1702)
Vincristine (tx:ncit:C933)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (1) | CD20 + | Acute Lymphoblastic Leukemia | Daunorubicin, Dexamethasone, Methotrexate, Rituximab, Vincristine |